Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Third-party verification removes any internal conflict of interest and provides researchers with objective, externally generated data supporting each production lot
doi: 10.1186/s12937-024-00934-4 65
Similar content being viewed by others Background Recombinant DNA and protein technologies have taken a leading role in many forms of research over the past 40 years [1]
Headaches, hallucinations, hemiparesis, and seizures are some of the most prominent behavioral manifestations observed when CRS and ICANS occur secondary to brain-targeted CAR-T therapy (Shimabukuro-Vornhagen et al., 2018)
US$ 24.59
US$ 20.68
US$ 26.06
US$ 28.01
US$ 29.64
US$ 22.47
